Literature DB >> 22631635

Silencing of the COPS3 gene by siRNA reduces proliferation of lung cancer cells most likely via induction of cell cycle arrest and apoptosis.

Xue-Mei Wang1, Jiu-Wei Cui, Wei Li, Lu Cai, Wei Song, Guan-Jun Wang.   

Abstract

The COPS3 gene has stimulating effect on cell proliferation and progression of osteosarcomas and related cells. However, the features of COPS3 and its potential application as a therapeutic target in other cancers has not yet been studied. In this study, therefore, the effect of COPS3 silencing via COPS3 siRNA on lung cancer cell proliferation was examined. Expression levels of COPS3 gene in COPS3 siRNA infected cells and control siRNA infected cells were compared with real time PCR and Western blot analysis. Cell proliferation levels were comprehensively analyzed by MTT, BrdU incorporationy, and colony formation assays. For mechanistic assessment the effects of COPS3 silencing on cell cycle and apoptosis were analyzed using flow cytometry. Results showed that successful silencing of the COPS3 gene at both translational and transcriptional levels significantly reduced the proliferation and colony formation by lung cancer cells (p<0.01). Flow cytometry showed cell cycle arrest in the G0/G1 phase after COPS3 silencing, and more importantly, apoptosis was induced as a result of COPS3 knockdown, which negatively affected cell survival. Therefore, these results provide another piece of important evidence that the COPS3 gene expressed in lung cancer cells may play a critical role in stimulating proliferation. Down-regulation of COPS3 could significantly inhibit lung cancer cell growth, which was most likely mediated via induction of cell cycle arrest in G0/G1 phase and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22631635     DOI: 10.7314/apjcp.2012.13.3.1043

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

Review 1.  siRNA delivery to the lung: what's new?

Authors:  Olivia M Merkel; Israel Rubinstein; Thomas Kissel
Journal:  Adv Drug Deliv Rev       Date:  2014-06-05       Impact factor: 15.470

Review 2.  Development of small RNA delivery systems for lung cancer therapy.

Authors:  Yu Fujita; Kazuyoshi Kuwano; Takahiro Ochiya
Journal:  Int J Mol Sci       Date:  2015-03-06       Impact factor: 5.923

3.  A meta-analysis of multiple matched copy number and transcriptomics data sets for inferring gene regulatory relationships.

Authors:  Richard Newton; Lorenz Wernisch
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

4.  Knockdown of COPS3 Inhibits Lung Cancer Tumor Growth in Nude Mice by Blocking Cell Cycle Progression.

Authors:  Jianan Pang; Xu Yan; He Cao; Lei Qian; Hua He; Huimin Tian; Fujun Han; Guanjun Wang; Xiao Chen; Yuguang Zhao; Ji-Fan Hu; Jiuwei Cui
Journal:  J Cancer       Date:  2017-04-09       Impact factor: 4.207

5.  Novel oncogene COPS3 interacts with Beclin1 and Raf-1 to regulate metastasis of osteosarcoma through autophagy.

Authors:  Fan Zhang; Taiqiang Yan; Wei Guo; Kunkun Sun; Shidong Wang; Xing Bao; Kuisheng Liu; Bingxin Zheng; Hongliang Zhang; Tingting Ren
Journal:  J Exp Clin Cancer Res       Date:  2018-07-03

Review 6.  Targeting the COP9 signalosome for cancer therapy.

Authors:  Wenqi Du; Ruicheng Zhang; Bilal Muhammad; Dongsheng Pei
Journal:  Cancer Biol Med       Date:  2022-03-21       Impact factor: 5.347

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.